Engflag

Buspan

Quick links to important sections

Buspan

Buspan_EN

Method of action: Antiparkinsonian

Treatment option: Biliary Bypass, Biliary Colic, Colic, Renal Colic, Irritable Bowel Syndrome, Cholecystitis, Peptic Ulcer

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Buspan

Property Description
Active ingredient Hyoscine Butylbromide (Scopolamine Butylbromide)
Forms Film-coated tablets, Injection solution, Suppositories
Pharmacological class Antispasmodic Agent (Muscarinic Antagonist)
Common purpose Relief of visceral spasm and associated cramping
Origin Synthetic derivative (Quaternary Ammonium Compound)

What Type of Medicine is Buspan and What is its Composition?

Buspan is a pharmaceutical entity fundamentally classified as an antispasmodic agent, or spasmolytic, whose primary function is to relieve painful muscle contractions known as spasms. Its activity centers on the single active ingredient, Hyoscine Butylbromide (INN), which is a synthetic derivative of scopolamine. This compound is categorized chemically as a Quaternary ammonium compound, a structure that limits its absorption into the central nervous system, thereby focusing its action peripherally. This focused action is consistent with its classification as an antispasmodic agent. The unique quaternary structure of Hyoscine Butylbromide is clinically recognized for providing this targeted peripheral effect, minimizing the general systemic effects often associated with older anticholinergics.

Available Forms and General Therapeutic Purpose

The Buspan preparation is available in several forms to suit different needs, including film-coated tablets for oral use, and both suppositories and an injection solution for alternative administration routes. The general therapeutic purpose of the medicine is the swift alleviation of discomfort associated with visceral spasm. This pain often manifests as sharp, colicky cramps, such as those that can arise in the gastrointestinal or biliary tracts. By using an anticholinergic effect to interrupt the nerve signals causing these involuntary muscle spasms, the drug acts to normalize muscle tone and reduce painful episodes. The availability of the injection solution is a key differentiating feature, allowing for rapid use where quick onset is critical for treating acute spasms.

What side effects are possible with Buspan?

The official safety profile for Hyoscine Butylbromide (Buspan) is based on its known peripheral anticholinergic properties, as documented by regulatory agencies.

Adverse Reaction Scope

Adverse effects are categorized by the frequency observed in clinical use and post-marketing experience:

  • Uncommon (ge 1/1,000 to <1/100): Tachycardia (fast heart rate), dry mouth, and skin reactions, including urticaria (hives), pruritus (itching), and dyshidrosis (abnormal sweating).
  • Rare (ge 1/10,000 to <1/1,000): Urinary retention (difficulty passing urine).
  • Frequency Not Known: Serious systemic events such as anaphylactic shock (including fatal outcomes) and severe hypotension (decreased blood pressure) have been reported, primarily following injection.

The most commonly affected System-Organ Classes include Cardiac Disorders, Gastrointestinal Disorders (dry mouth), Renal and Urinary Disorders (urinary retention), and Immune System Disorders (anaphylaxis).

Safety Restrictions and Populations

Official labeling imposes specific restrictions and safety considerations:

  • Safety-Related Restrictions: The medicine is contraindicated in conditions such as untreated narrow-angle glaucoma, myasthenia gravis, megacolon, or mechanical stenoses in the gastrointestinal or urinary tract.
  • Population Notes: Caution is advised in patients with prostatic hypertrophy due to the risk of worsening urinary retention. Use during pregnancy and lactation is generally not recommended due to insufficient safety data.
  • Time-Related Patterns: Adverse effects like fast heart rate and accommodation disorders may be transient, particularly after injection, and generally resolve after discontinuation of the medicine.

Regulatory Safety Summary

The regulatory safety profile highlights a range of expected anticholinergic reactions, primarily categorized as uncommon, while emphasizing the serious, though rare, risk of anaphylaxis. These classifications formally define the conditions, patient groups, and administration contexts that require specific safety consideration.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Buspan (Hyoscine Butylbromide) is documented in regulatory sources as an exaggeration of its core pharmacological effects, presenting as anticholinergic toxicity. The documented manifestations often include tachycardia (increased heart rate), dry mouth, accommodation disorders (difficulty focusing the eyes), urinary retention, skin redness, confusion, and stupor.

Severe Outcomes and Help-Seeking

Official labeling outlines severe, potentially life-threatening outcomes, including anaphylactic shock, respiratory paralysis, and cardiac arrest. It is noted that these adverse effects can be more serious or result in a fatal outcome in patients with underlying cardiac disease, such as heart failure or coronary heart disease.

Immediate medical advice must be sought if any signs of a suspected overdose occur, or if severe, unexplained abdominal pain persists or worsens. Urgent ophthalmological advice is also required if a painful, red eye with loss of vision develops.

Management Measures

Management, as described in official labeling, is primarily symptomatic and supportive. For severe manifestations, parasympathomimetics are indicated to counteract the anticholinergic effects. Procedural steps such as gastric lavage and the use of activated charcoal are documented for oral intoxication, and catheterization may be required for urinary retention.

Therapeutic Uses of Buspan

Quick Facts: Therapeutic Domain

  • May assist in the management of: Generalized anxiety disorder (GAD).
  • May provide relief for: Short-term symptoms of anxiety.
  • May be considered for: Individuals experiencing tension, worry, or restlessness associated with anxiety.

What Buspan Treats: Main Uses and Benefits

Buspan (Buspirone) is a medication that may be used for the management of anxiety disorders. Its primary function is to assist in the improvement of symptoms related to generalized anxiety disorder (GAD). This may include helping to manage persistent worry, feelings of tension, or associated physical symptoms such as irritability and restlessness.

Buspan may also be considered for the short-term relief of anxiety symptoms, as determined by a healthcare provider. The effects may begin to occur after consistent use for several weeks, and the full benefit of the medication may be observed over time. Patients and clinicians may discuss its suitability as a treatment option, particularly when managing anxiety or its symptoms.

This medication is typically not intended for anxiety or tension arising from the common stresses of daily living.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Buspirone (Buspan)

This section outlines the eligibility criteria and restrictions for Buspirone based strictly on authoritative government regulatory documentation.

Contraindicated Use (Must Not Be Used)

Buspirone is formally contraindicated and must not be used in patients with the following:

  • Hypersensitivity to the active substance or any of its inactive ingredients.
  • Concurrent or recent use of Monoamine Oxidase Inhibitors (MAOIs), including reversible MAOIs, within the last 14 days.
  • Severe renal impairment or severe hepatic impairment.
  • States of acute intoxication with alcohol, hypnotics, analgesics, or antipsychotic drugs.

Restricted or Not Recommended Use

Use is restricted or generally not recommended in several populations and conditions due to a lack of established safety or efficacy data, or specific clinical risks:

  • Pediatric Population (Under 18 Years): Safety and efficacy have not been established.
  • Pregnancy and Lactation: Use during pregnancy and breastfeeding is not generally recommended as safety is not established.
  • Comorbidities: Use requires caution in patients with mild-to-moderate renal or hepatic impairment, myasthenia gravis, and acute narrow-angle glaucoma.
  • Long-Term Use: The effectiveness for use lasting more than 3 to 4 weeks has not been established in controlled trials.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Buspan (Hyoscine Butylbromide) is primarily defined by its effects on the peripheral nervous system and gastrointestinal motility, as documented in regulatory information.

Interaction Scope and Classification

Classification Interacting Agents
Additive Pharmacodynamic Effects Anticholinergics, Beta-adrenergic agents
Diminution of Effects Dopamine Antagonists (e.g., Metoclopramide)
Absorption Modification Antacids, Adsorbent Antidiarrheals

Official Interaction Statements

  • Co-administration with other anticholinergic substances (including Tricyclic Antidepressants, Antihistamines, and certain Antipsychotics) may intensify the overall anticholinergic effects.
  • Concomitant treatment with Dopamine Antagonists (like Metoclopramide) may result in the diminution of effects for both drugs on the gastrointestinal tract.
  • The medicine's effect on gastrointestinal motility may delay the systemic absorption and pharmacologic effects of other oral medications.
  • To avoid reduced absorption, this medicine must be given at least one hour before Antacids or adsorbent antidiarrheals.
  • Patients are advised to abstain from alcohol due to the potential for an increased chance of certain side effects, as noted in some regulatory documentation.
  • Geriatric patients are identified in the official label as especially susceptible to the anticholinergic side effects (e.g., urinary retention).

Mechanism of Action

The mechanism of action is centered on the competitive antagonism of muscarinic acetylcholine receptors ( mAChRs) located on the smooth muscle cells of the visceral organs. Hyoscine Butylbromide blocks the binding site of the neurotransmitter Acetylcholine (ACh), thereby interrupting the efferent nerve impulses of the Parasympathetic Nervous System (PNS) that drive muscle contraction. The resulting physiological effect is the modulation of visceral smooth muscle tone and a change in motility frequency. Beyond receptor blockade, the mechanism prevents the subsequent intracellular signaling cascade within the muscle cell, specifically by limiting the release of calcium ions ( Ca^2+). Since Ca^2+ is the molecular trigger for muscle fiber shortening, preventing its release effectively halts the contraction process at the cellular level. This provides the final mechanistic link to the spasmolytic physiological consequence. Furthermore, the drug's structure, a Quaternary Ammonium Compound, is highly polar, a feature that prevents it from readily crossing the Blood-Brain Barrier (BBB). This structural constraint limits the molecule's action strictly to peripheral targets, preventing modulation of central cholinergic receptors.

Dosage and Administration Information

Instruction Map: How to use Buspan (Hyoscine Butylbromide) — Administration Guidelines

Administration Scope
Route of administration The medication is approved for both oral administration via tablets and parenteral routes, including Intravenous (IV), Intramuscular (IM), and Subcutaneous (SC) injection.
Dosing schedule For adult oral use, the standard range is 10 mg to 20 mg per dose, with a maximum daily limit of 80 mg. For acute parenteral administration, the typical dose is 20 mg to 40 mg, not to exceed 100 mg daily.
Timing in relation to meals (if applicable) Oral doses may be taken with or without food.
Preparation requirements (if applicable) Tablets must be swallowed whole with water; they must not be crushed or chewed. Intravenous injection must be performed slowly.
Age-group administration rules Oral use is 10 mg up to three times daily for children aged 6 to 11 years. Parenteral use in infants and young children is weight-based, not to exceed 1.2 mg/kg bodyweight per day.
Special procedural conditions The medication is strictly designated for short-term, intermittent use and should not be taken continuously without medical investigation. For patients on anticoagulant therapy, the IV or SC route must be used, as the IM route is restricted.

Instruction Classifications (High-Level)
Administration method type Oral and Parenteral (IV/IM/SC).
Frequency pattern As-needed (intermittent) up to four times daily for oral administration.
Use-context constraints Short-term use only; Anticoagulation status dictates the required injection route.

Connection to the overall use protocol

The instructions define a standardized protocol that permits administration via oral tablets for general, intermittent use or injection for acute management. The protocol specifies precise dose limits and frequency constraints while explicitly restricting the duration of use to short, intermittent courses.

Recent Clinical Evidence

Buspan: Overview of Clinical Evidence

Research on Acute Lower Back Pain (ALBP)

Research has investigated Buspan's relationship with reduced pain and the time to change in symptom scores in acute lower back pain (ALBP). A primary focus of the research was the compound's effect on pain scores and functional recovery.

  • One study found that the reduction in pain scores observed in participants receiving the compound was maintained over a 7-day period.
  • The compound was compared to placebo and other non-steroidal anti-inflammatory drugs (NSAIDs) in terms of reducing pain scores.

The combination of properties was explored in research investigating the management of inflammation and pain associated with ALBP. The compound's role in the reduction of symptoms was studied in relation to its pharmacological properties.

Safety and Tolerability Profile

Research also evaluated the safety profile of the compound in adult patients when used as directed.

  • The compound's tolerability profile was often evaluated in studies where participants received treatment for the shortest duration necessary, as this approach is associated with a lower risk of side effects.
  • In clinical trials, data showed that gastrointestinal adverse events represented the most frequently reported findings regarding side effects.
  • In studies, individuals with a history of stomach ulcers are often excluded from participation due to potential safety concerns.

Other Conditions Studied

Studies have also explored the potential role of the compound in alleviating muscle spasticity associated with chronic pain. These studies often focus on the compound's anti-inflammatory and centrally-acting properties.

  • In trials, the findings addressed the potential for addiction or dependence.
  • Further research is ongoing to assess long-term safety and effects on different populations.

Key Studies & References The clinical course of acute, subacute and persistent low back pain: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Buspan (FAQ)

Q: What is Buspan and how does it work?

Buspan is a prescription medicine containing buspirone, which is used to treat generalized anxiety disorder (GAD). Buspirone is in a class of medications called anxiolytics (anti-anxiety agents).

It works by affecting certain natural substances in the brain called neurotransmitters, such as serotonin and dopamine. This helps to balance brain chemistry and relieve the symptoms of anxiety, such as worry, tension, and irritability.

Q: How long does it take for Buspan to start working?

Buspan does not work right away to treat anxiety attacks. It usually takes about 2 to 4 weeks of regular use before you feel the full benefits of the medication and notice a significant improvement in your anxiety symptoms.

Because of this delayed effect, Buspan is not used for “as-needed” or acute relief of sudden anxiety or panic attacks. It is intended for long-term management of generalized anxiety disorder.

Q: Can I drink alcohol while taking Buspan?

It is generally recommended that you avoid or limit drinking alcohol while taking Buspan.

Both Buspan and alcohol can cause drowsiness, dizziness, and impaired judgment. Combining them can increase these side effects, making them more severe. This combination can also worsen your anxiety symptoms in some cases. Talk to your healthcare provider about how much alcohol, if any, is safe for you to consume.

Q: What are the common side effects of Buspan?

Some people may experience side effects when taking Buspan. Common side effects often include:

  • Dizziness
  • Nausea
  • Headache
  • Nervousness or excitement
  • Lightheadedness
  • Sleepiness or insomnia (trouble sleeping)

These side effects are usually mild and may decrease as your body adjusts to the medication. If side effects are persistent, severe, or concerning, you should discuss them with your healthcare provider.

Q: Will Buspan make me feel “high” or addicted?

Buspan is not considered a controlled substance and has a low risk of physical dependence or addiction when compared to some other anti-anxiety medications (such as benzodiazepines).

Unlike some drugs, Buspan does not typically cause a feeling of euphoria or a “high.” It is designed to relieve anxiety by balancing brain chemistry. However, it is important to take the medication exactly as prescribed by your healthcare provider and not to stop taking it suddenly without medical guidance.

Q: Is it safe to stop taking Buspan suddenly?

No, you should not stop taking Buspan suddenly without first talking to your healthcare provider. While Buspan is not typically associated with severe withdrawal, suddenly stopping the medication can cause withdrawal-like symptoms or a return of anxiety symptoms.

If your healthcare provider decides that you should stop taking Buspan, they will likely advise you to gradually reduce your dose over time. This process, called tapering, helps your body adjust and reduces the risk of uncomfortable side effects.

Q: Does Buspan interact with other medications?

Yes, Buspan can interact with several other medications, which could change how Buspan or the other medicine works, or increase the risk of side effects. Key interactions include:

  • MAO Inhibitors (MAOIs): Taking Buspan with or shortly after stopping an MAOI can cause a dangerous increase in blood pressure.
  • Certain Antidepressants: Combining Buspan with medicines that increase serotonin (like SSRIs) can increase the risk of a condition called serotonin syndrome.
  • Grapefruit Juice: Consuming large amounts of grapefruit juice can increase the level of buspirone in your blood, potentially leading to more side effects.

Always provide your healthcare provider with a complete list of all prescription, over-the-counter, and herbal products you are taking to ensure safe use of Buspan.

How should Buspan be stored and disposed of?

The official storage and disposal guidelines for Buspan (Hyoscine Butylbromide) are defined by the specific formulation to maintain product stability and ensure public safety.

Mandatory Storage Conditions

Form Temperature Requirement Protection Conditions
Tablets Store below 25 C or 30 C Protect from light and moisture
Injection Solution Store below 30 C Protect from light; Do not freeze

The medicine must be kept in its original package and stored out of the sight and reach of children.

Stability and Disposal

The injection solution is intended for single use; any unused contents of an opened ampoule must be immediately discarded. For all unused or expired tablets and solutions, disposal must follow local requirements. Medicines must not be thrown into household trash or wastewater; disposal should occur through designated pharmacy take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagTaiwan

Equivalent of Buspan found in:

A-Z Index: